HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Evelyne Ségal-Bendirdjian Selected Research

platinum-mono-para-quinacridine

1/2017Association of a Platinum Complex to a G-Quadruplex Ligand Enhances Telomere Disruption.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Evelyne Ségal-Bendirdjian Research Topics

Disease

18Neoplasms (Cancer)
03/2022 - 12/2003
8Acute Promyelocytic Leukemia
03/2022 - 12/2003
4Carcinogenesis
04/2009 - 09/2004
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2019 - 01/2016
3Leukemia
01/2012 - 06/2006
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022 - 10/2014
2Lung Neoplasms (Lung Cancer)
11/2019 - 01/2019
1Breast Neoplasms (Breast Cancer)
03/2022
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2022
1Carcinoma (Carcinomatosis)
11/2019
1Ovarian Neoplasms (Ovarian Cancer)
11/2017
1Glioblastoma (Glioblastoma Multiforme)
04/2015
1Glioma (Gliomas)
04/2015
1Neuroblastoma
11/2012
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
05/2011
1Disease Progression
06/2006

Drug/Important Bio-Agent (IBA)

13Telomerase (Telomerase Reverse Transcriptase)IBA
03/2022 - 12/2003
7RetinoidsIBA
01/2022 - 12/2003
5EnzymesIBA
01/2018 - 06/2006
4PlatinumIBA
11/2019 - 01/2017
3Tretinoin (Retinoic Acid)FDA LinkGeneric
03/2022 - 10/2014
3RNA (Ribonucleic Acid)IBA
11/2019 - 11/2012
3Cisplatin (Platino)FDA LinkGeneric
11/2019 - 09/2004
2Proteins (Proteins, Gene)FDA Link
11/2019 - 11/2012
2SaltsIBA
11/2019 - 01/2019
2LigandsIBA
01/2019 - 04/2015
2NeurotensinIBA
01/2019 - 11/2017
2Pharmaceutical PreparationsIBA
01/2018 - 11/2017
2RibonucleoproteinsIBA
11/2012 - 06/2006
1Biomarkers (Surrogate Marker)IBA
03/2022
1AntibodiesIBA
11/2019
1Monoclonal AntibodiesIBA
01/2019
1Long Noncoding RNAIBA
01/2018
1SR 48692IBA
11/2017
1Neurotensin Receptors (Neurotensin Receptor)IBA
11/2017
1Carboplatin (JM8)FDA LinkGeneric
11/2017
1Messenger RNA (mRNA)IBA
11/2017
1telomerase RNA (bTR)IBA
03/2017
1human core proteinIBA
03/2017
1ethyleneIBA
01/2017
1platinum-mono-para-quinacridineIBA
01/2017
1DiaminesIBA
01/2017
1HLA-DR Antigens (HLA-DR)IBA
01/2016
1Peptides (Polypeptides)IBA
01/2016
1pyridineIBA
04/2015
1IsoenzymesIBA
05/2013
1Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA
05/2013
1Biological ProductsIBA
11/2012
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
11/2012
1Imatinib Mesylate (Gleevec)FDA Link
05/2011
1TNF-Related Apoptosis-Inducing LigandIBA
09/2004
1Etoposide (VP 16)FDA LinkGeneric
09/2004
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2004
1Retinoid X Receptors (Retinoid X Receptor)IBA
12/2003
1Retinoic Acid Receptor alphaIBA
12/2003
1Retinoic Acid Receptors (Retinoic Acid Receptor)IBA
12/2003

Therapy/Procedure

7Therapeutics
01/2020 - 12/2003
3Drug Therapy (Chemotherapy)
11/2017 - 01/2005
2Immunotherapy
01/2019 - 01/2016
1Neoadjuvant Therapy
11/2019
1Transplantation
04/2015